Cargando…
Comprehensive phenotyping and biological marker discovery
There is an enormous unmet need for biological markers to characterize disease type, status, progression, and response to therapy. We are developing and applying an integrated bioanalytical platform and clinical research program to facilitate comprehensive differential phenotyping of patient samples...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851087/ https://www.ncbi.nlm.nih.gov/pubmed/12364815 http://dx.doi.org/10.1155/2002/178798 |
_version_ | 1782294222137720832 |
---|---|
author | Kantor, Aaron B. |
author_facet | Kantor, Aaron B. |
author_sort | Kantor, Aaron B. |
collection | PubMed |
description | There is an enormous unmet need for biological markers to characterize disease type, status, progression, and response to therapy. We are developing and applying an integrated bioanalytical platform and clinical research program to facilitate comprehensive differential phenotyping of patient samples and enable the discovery of biomarkers. The platform employs high-throughput, quantitative analysis for the characterization of thousands of parameters including cell populations, cell-surface antigen density, soluble proteins and soluble low molecular weight biomolecules, from small-volume biological samples in a clinical research laboratory-like setting. |
format | Online Article Text |
id | pubmed-3851087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38510872014-02-03 Comprehensive phenotyping and biological marker discovery Kantor, Aaron B. Dis Markers Other There is an enormous unmet need for biological markers to characterize disease type, status, progression, and response to therapy. We are developing and applying an integrated bioanalytical platform and clinical research program to facilitate comprehensive differential phenotyping of patient samples and enable the discovery of biomarkers. The platform employs high-throughput, quantitative analysis for the characterization of thousands of parameters including cell populations, cell-surface antigen density, soluble proteins and soluble low molecular weight biomolecules, from small-volume biological samples in a clinical research laboratory-like setting. IOS Press 2002 2002-10-21 /pmc/articles/PMC3851087/ /pubmed/12364815 http://dx.doi.org/10.1155/2002/178798 Text en Copyright © 2002 Hindawi Publishing Corporation. |
spellingShingle | Other Kantor, Aaron B. Comprehensive phenotyping and biological marker discovery |
title | Comprehensive phenotyping and biological marker discovery |
title_full | Comprehensive phenotyping and biological marker discovery |
title_fullStr | Comprehensive phenotyping and biological marker discovery |
title_full_unstemmed | Comprehensive phenotyping and biological marker discovery |
title_short | Comprehensive phenotyping and biological marker discovery |
title_sort | comprehensive phenotyping and biological marker discovery |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851087/ https://www.ncbi.nlm.nih.gov/pubmed/12364815 http://dx.doi.org/10.1155/2002/178798 |
work_keys_str_mv | AT kantoraaronb comprehensivephenotypingandbiologicalmarkerdiscovery |